trending Market Intelligence /marketintelligence/en/news-insights/trending/s8s9iz_zp_rkqzer7dhxdw2 content esgSubNav
In This List

Oncobiologics names director

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Oncobiologics names director

Oncobiologics Inc. appointed Joerg Windisch as director, effective March 23.

He was appointed to fill the vacancy created by Yezan Haddadin's resignation from the board, the company said March 27 in an SEC filing.

Windisch is currently COO of Polpharma Biologics.

Cranbury, N.J.-based Oncobiologics is a clinical-stage biopharmaceutical company which focuses on developing biosimilars in immunology and oncology disease areas.